Literature DB >> 21743687

Codeine containing cough syrup addiction in assam and nagaland.

N S Wairagkar1, J Das, S Kumar, J Mahanta, K Satyanarayana, R K Phukan, M Chetia, S K Goswami.   

Abstract

The drug abuse monitoring study of Regional Medical Research Center, Dibrugarh, reported 181 and 395 addicts from the states of Assam and Nagaland respectively in one year. Of these, 48 (26.5%) and 49(12.4%) cases were contributed by the primary abuse of codeine containing cough syrups. A11 addicts were males in their early twenties. Most of the addicts were unmarried and educated up to matriculation. The majority of addicts in Assam were Hindus (85.4%) and in Nagaland Christians (81.63%). Unemployment was predominant in both the groups. The mean age for the first use of codeine cough syrup was 17.44 years (Assam) and 15.77 years (Nagaland). Nagaland had more chronic abusers. Addicts were used the oral route several times a day and friends were the main source of introduction. Mild forms of physical and psychiatric disorders were reported Easy over-the-counter availability, lesser expenditure, milder withdrawals and ease of consumption without secrecy were some of the reasons for the emergence of this new form of addiction in Assam and Nagaland.

Entities:  

Keywords:  Codeine; addiction; over-the-counter cough syrups

Year:  1994        PMID: 21743687      PMCID: PMC2972479     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  8 in total

1.  Abuse of "BRON": a Japanese OTC cough suppressant solution containing methylephedrine, codeine, caffeine and chlorpheniramine.

Authors:  J Ishigooka; Y Yoshida; M Murasaki
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1991       Impact factor: 5.067

2.  Indices of drug misuse for prescription drugs.

Authors:  H Davis; C Baum; D J Graham
Journal:  Int J Addict       Date:  1991-07

3.  Abuse of codeine separated from over-the-counter drugs containing acetylsalicylic acid and codeine.

Authors:  S Jensen; A C Hansen
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

4.  A profile of alcohol and prescription drug abuse in a high-risk community-based elderly population.

Authors:  M J Jinks; R R Raschko
Journal:  DICP       Date:  1990-10

Review 5.  Safe use of codeine in the recovering alcoholic or addict.

Authors:  C J Stock
Journal:  DICP       Date:  1991-01

6.  Fatalities associated with an acute overdose of glutethimide (Doriden) and codeine.

Authors:  F H Bender; J V Cooper; R Dreyfus
Journal:  Vet Hum Toxicol       Date:  1988-08

7.  Differential sensitivity to physical dependence on morphine and codeine in three inbred strains of mice.

Authors:  T Suzuki; K Otani; M Misawa
Journal:  Jpn J Pharmacol       Date:  1991-12

8.  Obsessive-compulsive disorder in people that abuse codeine.

Authors:  M Senjo
Journal:  Acta Psychiatr Scand       Date:  1989-06       Impact factor: 6.392

  8 in total
  5 in total

1.  Promethazine use among chronic pain patients.

Authors:  Kara L Lynch; Brad J Shapiro; Diana Coffa; Scott P Novak; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2015-02-26       Impact factor: 4.492

2.  Personal construction of cough medicine among young substance abusers in Hong Kong.

Authors:  Daniel T L Shek
Journal:  ScientificWorldJournal       Date:  2012-04-19

3.  A case report of over-the-counter codeine dependence as consequence of self-medication for premature ejaculation.

Authors:  Sethulakshmi Sreevalsam Anil; Badr Ratnakaran; Nisha Suresh
Journal:  J Family Med Prim Care       Date:  2017 Oct-Dec

4.  Correlates of opium use: retrospective analysis of a survey of tribal communities in Arunachal Pradesh, India.

Authors:  Himanshu K Chaturvedi; Jagadish Mahanta; Ram C Bajpai; Arvind Pandey
Journal:  BMC Public Health       Date:  2013-04-10       Impact factor: 3.295

Review 5.  Antitussives and substance abuse.

Authors:  Jarrett M Burns; Edward W Boyer
Journal:  Subst Abuse Rehabil       Date:  2013-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.